| Potential anti‐cancer effects of virgin olive oil phenolson colorectal carcinogenesis models in vitro CIR Gill, A Boyd, E McDermott, M McCann, M Servili, R Selvaggini, ... International Journal of Cancer 117 (1), 1-7, 2005 | 221 | 2005 |
| Differential effects of isoflavones and lignans on invasiveness of MDA-MB-231 breast cancer cells in vitro PJ Magee, H McGlynn, IR Rowland Cancer Letters 208 (1), 35-41, 2004 | 152 | 2004 |
| Effect of colonic bacterial metabolites on Caco-2 cell paracellular permeability in vitro R Hughes, MJ Kurth, V McGilligan, H McGlynn, I Rowland Nutrition and cancer 60 (2), 259-266, 2008 | 138 | 2008 |
| Components of olive oil and chemoprevention of colorectal cancer YZHY Hashim, M Eng, CIR Gill, H McGlynn, IR Rowland Nutrition reviews 63 (11), 374-386, 2005 | 138 | 2005 |
| Inhibitory effects of olive oil phenolics on invasion in human colon adenocarcinoma cells in vitro YZHY Hashim, IR Rowland, H McGlynn, M Servili, R Selvaggini, ... International journal of cancer 122 (3), 495-500, 2008 | 132 | 2008 |
| Bioavailability of n–3 polyunsaturated fatty acids (PUFA) in foods enriched with microencapsulated fish oil JMW Wallace, AJ McCabe, PJ Robson, MK Keogh, CA Murray, PM Kelly, ... Annals of Nutrition and Metabolism 44 (4), 157-162, 2000 | 131 | 2000 |
| The Effect of Cruciferous and Leguminous Sprouts on Genotoxicity, In vitro and In vivo CIR Gill, S Haldar, S Porter, S Matthews, S Sullivan, J Coulter, H McGlynn, ... Cancer Epidemiology Biomarkers & Prevention 13 (7), 1199-1205, 2004 | 118 | 2004 |
| Role of mammalian lignans in the prevention and treatment of prostate cancer MJ McCann, CIR Gill, H McGlynn, IR Rowland Nutrition and cancer 52 (1), 1-14, 2005 | 86 | 2005 |
| Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation DMP Morrow, PEE Fitzsimmons, M Chopra, H McGlynn Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 480 …, 2001 | 57 | 2001 |
| Annexin II cell surface and mRNA expression in human acute myeloid leukaemia cell lines SA Olwill, H McGlynn, WS Gilmore, HD Alexander Thrombosis research 115 (1-2), 109-114, 2005 | 44 | 2005 |
| Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro MJ McCann, CIR Gill, T Linton, D Berrar, H McGlynn, IR Rowland Molecular nutrition & food research 52 (5), 567-580, 2008 | 40 | 2008 |
| Annexin A2 expression during cellular differentiation in myeloid cell lines WS Gilmore, S Olwill, H McGlynn, HD Alexander Biochemical Society Transactions 32 (6), 1122-1123, 2004 | 36 | 2004 |
| Docosahexaenoic acid reduces in vitro invasion of renal cell carcinoma by elevated levels of tissue inhibitor of metalloproteinase-1 AJ McCabe, JMW Wallace, WS Gilmore, H McGlynn, SJ Strain The Journal of Nutritional Biochemistry 16 (1), 17-22, 2005 | 34 | 2005 |
| All‐trans retinoic acid‐induced downregulation of annexin II expression in myeloid leukaemia cell lines is not confined to acute promyelocytic leukaemia SA Olwill, H McGlynn, WS Gilmore, HD Alexander British journal of haematology 131 (2), 258-264, 2005 | 27 | 2005 |
| All‐trans retinoic acid‐induced downregulation of annexin II expression in myeloid leukaemia cell lines is not confined to acute promyelocytic leukaemia SA Olwill, H McGlynn, WS Gilmore, HD Alexander British journal of haematology 131 (2), 258-264, 2005 | 25 | 2005 |
| The effect of eicosapentanoic acid on matrix metalloproteinase gene expression AJ McCabe, J Wallace, WS Gilmore, JJ Strain, H McGlynn Lipids 34 (Suppl 1), S217-S218, 1999 | 23 | 1999 |
| Molecular, cytogenetic and genetic abnormalities in MDS and secondary AML RA Padua, A McGlynn, H McGlynn Cancer Treat Res 108, 111-57, 2001 | 21 | 2001 |
| FMS mutations in patients following cytotoxic therapy for lymphoma A Baker, P Cachia, S Ridge, H McGlynn, R Clarke, J Whittaker, A Jacobs, ... Leukemia research 19 (5), 309-318, 1995 | 21 | 1995 |
| RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia. C Taylor, H McGlynn, G Carter, AH Baker, N Warren, SA Ridge, G Owen, ... Leukemia 9 (3), 466-470, 1995 | 20 | 1995 |
| Biological consequences of a point mutation at codon 969 of the FMS gene H McGlynn, AH Baker, RA Padua Leukemia research 22 (4), 365-372, 1998 | 17 | 1998 |
RA PaduaUniversite Paris-DiderotVerified email at inserm.fr
